Information and Disclosures
Key AI-ECG Studies
PRESENT-SHD — Dhingra…Khera et al. JACC 2025 (Winner, William W. Parmley Prize, ACC 2026)
Heart Failure Risk Stratification using ECG Images — Dhingra…Khera et al. EHJ 2025
Single-lead ECGs for Predicting Heart Failure Risk — Dhingra*, Aminorroaya*…Khera et al. JAMA Cardiology 2025
HCM Detection using AI applied to ECG Images — Sangha*, Dhingra*…Khera et al. Nature Cardiovascular Research 2025
Disclosures
Dr. Dhingra does not have any disclosures.
Dr. Khera is an Associate Editor of JAMA. He receives support from the National Institutes of Health (under awards R01AG089981, R01HL167858, and K23HL153775) and the Doris Duke Charitable Foundation (under award 2022060). He also receives research support, through Yale, from Bristol-Myers Squibb, Novo Nordisk, and BridgeBio. He serves on the steering committee for the FocusHTG registry, funded by Ionis Pharmaceuticals. In addition, Dr. Khera is a coinventor of U.S. Pending Patent Applications WO2023230345A1, US20220336048A1, 63/484,426, 63/508,315, 63/580,137, 63/606,203, 63/619,241, 63/562,335, and 63/346,610. Dr. Khera is also a co-founder of Ensight-AI and Evidence2Health, precision health platforms to improve evidence-based cardiovascular care.
Acknowledgment
Icons in the slide deck were designed using resources from Flaticon.com